ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BOLT Bolt Biotherapeutics Inc

1.11
-0.05 (-4.31%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 122,489
Bid Price 0.84
Ask Price 1.59
News -
Day High 1.20

Low
0.84

52 Week Range

High
2.03

Day Low 1.10
Share Name Share Symbol Market Stock Type
Bolt Biotherapeutics Inc BOLT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -4.31% 1.11 23:00:10
Open Price Low Price High Price Close Price Previous Close
1.16 1.10 1.20 1.11 1.16
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
156 122,489 US$ 1.14 US$ 139,403 - 0.84 - 2.03
Last Trade Type Quantity Price Currency
18:22:50 formt 183 US$ 1.11 USD

Bolt Biotherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
42.14M 37.97M - 7.88M -69.2M -1.82 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Bolt Biotherapeutics News

Date Time Source News Article
3/21/202415:05GlobeNewswire Inc.Bolt Biotherapeutics Reports Fourth Quarter and Full-Year..
3/06/202412:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202412:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202406:00GlobeNewswire Inc.Bolt Biotherapeutics to Present at the TD Cowen 44th Annual..
2/12/202420:41Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
2/06/202412:09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership..
12/21/202306:30GlobeNewswire Inc.Pacira Appoints Frank D. Lee as Chief Executive Officer
12/13/202312:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/05/202306:00GlobeNewswire Inc.Bolt Biotherapeutics Enrolls First Patient in Phase 2..
11/09/202315:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:08Edgar (US Regulatory)Form 8-K - Current report
11/09/202315:05GlobeNewswire Inc.Bolt Biotherapeutics Reports Third Quarter 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BOLT Message Board. Create One! See More Posts on BOLT Message Board See More Message Board Posts

Historical BOLT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.151.211.091.1661,496-0.04-3.48%
1 Month1.411.561.091.28115,982-0.30-21.28%
3 Months1.101.561.001.23131,7460.010.91%
6 Months1.001.560.841.13115,5150.1111.00%
1 Year1.602.030.841.24120,433-0.49-30.63%
3 Years24.6727.870.844.65200,992-23.56-95.50%
5 Years26.1043.070.847.63210,182-24.99-95.75%

Bolt Biotherapeutics Description

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Your Recent History

Delayed Upgrade Clock